Coherus BioSciences (NASDAQ: CHRS) reported Q4 EPS of ($1.47), versus ($3.68) reported last year. Revenue for the quarter came in at $6.5 million, versus $1.2 million reported last year.

For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.

Earnings

Coherus BioSciences (CHRS) Files $100M Common SHelfMarch 23, 2015 4:32 PM Form S-1 Coherus BioSciences, March 23, 2015 4:28 PM Form 10-K Coherus BioSciences, For: Dec 31March 23, 2015 4:25 PM Coherus BioSciences Reports Fourth Quarter and Year End 2014 Financial and Operating ResultsMarch 23, 2015 4:00 PM Coherus BioSciences Reports Fourth Quarter and Year End 2014 Financial and Operating ResultsMarch 23, 2015 4:00 PM Coherus BioSciences Reports Fourth Quarter and Year End 2014 Financial and Operating ResultsMarch 23, 2015 4:00 PM